Psychotropic Medication Use in Dementia

Similar documents
Use of Psychotropic Medications in Older Adults with Dementia!

ALAMEDA COUNTY BEHAVIORAL HEALTH CARE SERVICES MEDICATION FORMULARY

Medications for Anxiety & Behavior in Williams Syndrome. Disclosure of Potential Conflicts. None 9/22/2016. Evaluation

Medications and Children Disorders

Introduction to Drug Treatment

Management of Behavioral Problems in Dementia

Psychotropic Medications Archana Jhawar, PharmD, BCPP Clinical Faculty of UIC Pharmacy Practice Clinical Psychiatric Pharmacist Jesse Brown VA

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Guide to Psychiatric Medications for Children and Adolescents

PSYCHIATRY DRUG ALERTS, VOLUME XXVIII, 2014 INDEX

The use of prescription psychotropic medication in

South London and the Maudsley NHS Foundation Trust Medicines Formulary

Index. Note: Page numbers of article titles are in boldface type. A ADHD. See Attention-deficit/hyperactivity disorder (ADHD) b-adrenergic blockers

Dementia Medications Acetylcholinesterase Inhibitors (AChEIs) and Glutamate (NMDA) Receptor Antagonist

Antidepressants. Dr Malek Zihlif

Cognitive enhancers PINCH ME. Anticholinergic burden BPSD. Agitation, Aggression and antipsychotics

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

Drugs, Sleep & Wakefulness. Brian Koo Reena Mehra MD MS Kingman Strohl MD

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

NorthSTAR. Pharmacy Manual

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Objectives. Mental Health Info MEDICATION USE IN ASSISTED LIVING FACILITIES FOR MENTAL HEALTH ISSUES 11/12/2018

Appendix: Psychotropic Medication Reference Tables

Depression in Late Life

BIOLOGICAL TREATMENT IN PSYCHIATRY. PTE ÁOK Dept.of Psychiatry Pécs

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Index. E Elderly and dementia, 2 Epilepsy, 59 Escitalopram, 51, 87 Estazolam, 101 Extrapyramidal symptoms (EPS), 18

MO Medicaid Foster Care Drugs FY10-FY14

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.

Psychobiology Handout

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Retrospective Drug Use Review for the Use of Psychotropic Medications in Children

Joint Formulary for Psychotropic Medication.

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

This document has been produced in collaboration with the Lancashire Commissioning Support Unit

BEHAVIORAL PROBLEMS IN DEMENTIA

4/2/13 COMMON CLASSES OF MEDICATIONS. Child & Adolescent Behavioral Medicine & Medication Therapies. Behavioral Medicine & Medication Therapies

DEMENTIA AND MEDICATION

Policy Evaluation: Low Dose Quetiapine Safety Edit

Prescriber s Guide. Stahl s Essential Psychopharmacology

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?

Affective or Mood Disorders. Dr. Alia Shatanawi March 12, 2018

Mood Disorders.

PRACTICAL MANAGEMENT OF DEPRESSION IN OLDER ADULTS. Lee A. Jennings, MD MSHS Assistant Professor Division of Geriatrics, UCLA

Psychopharmacology. Psychopharmacology. Hamish McAllister-Williams Reader in Clinical. Department of Psychiatry, RVI

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Anti-Depressant Medications

Schedule FDA & literature based indications

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

10/5/2017. BEHAVIORAL and PSYCHOLOGICAL SYMPTOMS in DEMENTIA (BPSD) Dr. Shah MD, MPH Braodlawns Medical Center DISCLOSURE

Study Guidelines for Quiz #1

A Basic Approach to Mood and Anxiety Disorders in the Elderly

Chapter 161 Antipsychotics

Medicines Formulary BNF Section 4 Central Nervous System

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Guidelines/Supporting Studies* FDA Label Information Additional Information/Commentsxc` Gene(s)/Level of evidence

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

Depression in Older Adults. Paul Boulware, MD Arizona Neurological Institute April 22, 2012

Antipsychotics for Dementia Under Control or Over-Prescribed?

12/17/2012. Unnecessary Drugs

2/12/2016. Drugs and Dementia in the Hospice Patient. Jim Joyner, Pharm.D., C.G.P. Director of Clinical Operations Outcome Resources

Mental illness A Broad Overview. Dr H Pathmanandam March 2017

2015 Update on Psychotropics

Psychiatric Medication Guide

CHILD & ADOLESCENT PSYCHIATRY ALERTS, VOLUME XIV, 2012 INDEX

48 th Annual Meeting. Clinical Pearls: Depression, Insomnia and Bipolar Disorder DSM-5. Disclosure. Depression. Patient Case. Objectives 7/19/2014

Pharmacological Treatment of Anxiety & Depressive Disorders

Treatment Options for Bipolar Disorder Contents

BRIEF ANTIDEPRESSANT OVERVIEW. Casey Gallimore, Pharm.D., M.S.

Any interventions, where RCTs in PD are not available, are not included in the tables.

Antipsychotic Medications

Antipsychotic Use in the Elderly

HEDIS BEHAVIORAL HEALTH RESOURCE GUIDE

Anxiety Disorders.

Psychotropic Strategies Handout Package

Psychiatric Medications. Positive and negative effects in the classroom

3. Atypical antidepressants

Katee Kindler, PharmD, BCACP

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project

USING ANTIPSYCHOTICS TO TREAT THE BEHAVIORAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD)- WHAT IS THE EVIDENCE?

Lewy Body Disease. Dementia Education for the First Responder July 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Reducing the Anxiety of Pediatric Anxiety Part 2: Treatment

Mixing and Matching: Layering Medications as Family Physicians

Psychiatry in Primary Care: What is the Role of Pharmacist?

Medicine Related Falls Risk Assessment Tool (MRFRAT)

PSYCHIATRY INTAKE FORM

Manual of Clinical Psychopharmacology

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Insomnia: Updates in Medical Management. Michael Newnam M.D.

Presenter Disclosure. Objectives 6/5/2017. Depression, Anxiety, PTSD: A Focus on Pharmacotherapy

The Road to Rehabilitation

Perinatal Mental Health: Prescribing Guidance for Trust Prescribers and GPs

Professor David Castle. Ms. Nga Tran. St. Vincent s Mental Health Level 2, 46 Nicholson Street, Fitzroy Vic 3065

Transcription:

Psychotropic Medication Use in Dementia Marie A DeWitt, MD Diplomate of the American Board of Psychiatry and Neurology, Specialization in Psychiatry & Subspecialization in Geriatric Psychiatry Staff Physician, Mental Health Care Line Michael E. DeBakey VA Medical Center Assistant Professor, Menninger Dept of Psychiatry & Behavioral Sciences Baylor College of Medicine

None Disclosures

Outline Epidemiology of psychiatric conditions in older adults Psychotropic medications and their risks Clinical decision making

Epidemiology of Psychiatric Conditions in Dementia Anxiety Apathy Depression Irritability Sleep disturbance Eating disturbance Disinhibition Agitation/Aggression Psychosis Hallucinations Delusions

History Passage of OBRA 1987 to protect residents of LTC from medically unnecessary medications (and physical restraints) being used for convenience Use of psychotropic medications exposes patients to adverse side effects and can lead to deterioration of medical and cognitive status

Psychotropic Medications Antidepressants Anxiolytics, sedatives, and hypnotics Stimulants Mood stabilizers Neuroleptics Cognitive enhancers/stabilizers

Antidepressants

Antidepressant Categories SSRIs and SNRIs TCAs MAOIs Miscellaneous

Indications/Uses FDA approval Depression Anxiety Other uses Irritability Impulsivity Sleep aid

Antidepressants SSRIs Fluvoxamine, fluoxetine, paroxetine, citalopram, sertraline, escitalopram All ages Gastrointestinal upset Serotonin syndrome Akathisia Especially in older adults Hyponatremia Falls/hip fractures QTc prolongation (citalopram) Osteoporosis Anticholinergic side effects (some) Increased risk of bleeding if on anticoagulants

Antidepressants SNRIs Venlafaxine, duloxetine All ages Gastrointestinal upset Serotonin syndrome Akathisia Especially in older adults Hyponatremia Hypertension Falls?/hip fractures? Osteoporosis? Increased risk of bleeding if on anticoagulants?

Antidepressants TCAs Amitriptyline, climipramine, desipramnie, doxepin, imipramine, nortriptyline, protriptyline, trimipramine All ages Gastrointestinal upset Serotonin syndrome Akathisia Especially in older adults Anticholinergic side effects Cardiac dysrhythmias Hyponatremia Falls/hip fracture Osteoporosis? Increased risk of bleeding if on anticoagulants?

Antidepressants MAOIs Isocarboxacid, phenelzine, selegiline (oral and patch), tranylcypromine All ages Gastrointestinal upset Hypertensive crisis Serotonin syndrome Especially in older adults Anticholinergic side effects Cardiac dysrhythmias Hyponatremia Falls? Osteoporosis? Increased risk of bleeding if on anticoagulants?

Antidepressants Miscellaneous Bupropion Mirtazapine Trazodone Bupropion Mirtazapine Trazodone Anticholinergic/co nfusion Blood dyscrasias Orthostasis Psychosis? Sedation Sedation Decreased appetite? Increased appetite Cardiac dysrhythmias

Anxiolytics, Sedatives, & Hypnotics

Anxiolytics SSRIs, SNRIs, TCAs, and MAOIs Benzodiazepines Miscellaneous Buspirone, trazodone Propranolol, clonidine Antihistimines Antiepileptics (AEDs) * Medications listed on this slide are not necessarily FDA approved to treat anxiety

Anxiolytics Benzodiazepines Chlordiazepoxide, diazepam, alprazolam, triazolam, estazolam, flurazepam, chlorazepate Lorazepam, oxazepam, temazepam Do not require oxidation

Anxiolytics Benzodiazepines FALLS, FALLS, FALLS!!! CONFUSION, CONFUSION, CONFUSION!!! Paradoxical reactions More likely to have withdrawal symptoms (and to have these symptoms misrecognized) Dementia Depression Misuse

Anxiolytics Miscellaneous Buspirone Trazodone mild anticholinergic effects, sedation Propranolol, clonidine hypotension, can potentially address 2 problems with 1 medication Antihistamines tend to be anticholinergic

Sedative/Hypnotics Benzodiazepines Non-benzodiazepine hypnotics Zolpidem Zaleplon Eszopiclone Melatonin receptor agonist: Ramelteon Miscellaneous Trazodone, mirtazapine, and chloral hydrate

Sedative/Hypnotics Non-benzodiazepine hypnotics Have many of the same side effects as benzodiazepines including Falls Confusion Misuse

Sedative/Hypnotics Melatonin receptor agonist: Ramelteon Generally well tolerated Miscellaneous Trazodone, mirtazapine Chloral hydrate similar to alcohol * Medications listed on this slide are not necessarily FDA approved to treat sleep disorders

Stimulants

Stimulants May be helpful for apathy, amotivation, depression Buproprion Anticholinergic properties May worsen anxiety Methylphenidate Tachycardia, hypertension, confusion, hallucinations May worsen anxiety * Medications listed on this slide are not necessarily FDA approved to treat apathy or depression

Mood Stabilizers

Mood Stabilizers May be useful for impulsivity and irritability Divalproex, valproic acid, valproate Dizziness, falls, elevated liver enzymes, elevated ammonia, weight gain, hair loss Carbamazepine Blood dyscrasias, elevated liver enzymes, interactions with other medications * Medications listed on this slide are not necessarily FDA approved to treat impulsivity or irritability

Neuroleptics

Neuroleptics Typical (first generation) Chlorpromazine, thioridazine, trifluoperazine, fluphenazine, perphenazine, prochlorperazine, thiothixene, loxapine, pimozide, haloperidol Atypical (second generation) Clozapine, risperidone, olanzapine, quetiapine, ziprasidone, aripiprazole

Appropriate indications Acute psychotic episode, atypical psychosis, brief reactive psychosis Inappropriate indications Neuroleptics Agitated behaviors that do not represent danger to patient or others Schizophrenia, schizoaffective disorder, schizophreniform disorder Delusional disorder Huntington s disease Mood disorder with psychotic features Tourette s syndrome Anxiety, nervousness Depression without psychotic features Fidgeting, restlessness, wandering Impaired memory Indifference to surroundings, poor self care Short term (<7 days) treatment of hiccups, pruritis, nausea, or vomiting Organic mental syndromes including dementia and delirium with associated psychotic and/or agitated behaviors* Insomnia Uncooperativeness, unsociability * Medications listed on this slide are not FDA approved to treat problematic behaviors associated with dementia

Neuroleptics All ages Especially in older adults Weight gain Diabetes/metabolic syndrome Sedation Akathisia Dystonic reactions Sudden death (black box) EPS/Parkinsonism Anticholinergic effects Cardiac dysrhythmias Hyponatremia Seizures

Black Box Warning Increased risk of death when used in elderly patients treated for dementia-related psychosis Atypicals 2005 Typicals 2008

Cognitive Enhancers

Cognitive Enhancers Acetylcholinesterase inhibitors Donepezil, galantamine, rivastigmine Most common side effects: GI, vivid dreams (donepezil) Peripheral cholinergic side effects (cardiac) NMDA antagonist Memantine Most common side effect: GI Paradoxical agitation

Cognitive Enhancers FDA approval Alzheimer s disease/dementia Evidence suggests beneficial in vascular dementia, dementia related to Parkinson s disease, and perhaps in some FTD Evidence suggests beneficial in neuropsychiatric symptoms of dementia!

Guidelines for Use of Psychotropic Medicinations Appropriate and documented diagnosis associated with medication being prescribed Try and document trials of behavioral management Document assessment of medication s side effects Document benefit of medication for resident Documentation of dose reduction trial Explanation for continued medication

Clinical Decision Making

Clinical Decision Making What is the issue/behavior? What might be causing it or contributing to it? Is there a way to quantify or measure the degree of symptomatology (e.g., a screening instrument)? Is it an issue that can be completely or partially addressed without medication?

Clinical Decision Making So, a medication is needed Is there a medication that the individual is already on that can be adjusted to address the behavior? What are the individual s comorbidities and do they prevent the use of any medications? What are the most benign medications that can be used? Are there any side effect profiles that can be useful?

Clinical Decision Making Once on medication Monitor and document response of symptoms Monitor and document screening for side effects (e.g., sodium, falls, AIMS) Conduct periodic trials of a decreased dose or taper off the medication to determine if it s still needed